MWP
KZIA

MYCIO Wealth Partners’s Kazia Therapeutics KZIA Stock Holding History

MYCIO Wealth Partners’s Portfolio KZIA Stock Details KZIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-10
Closed -$5K – 777
2015
Q3 		$5K Hold
10
– – ﹤0.01% 660
2015
Q2 		$8K Buy
+10
New +$11.3K ﹤0.01% 548

Other funds holding KZIA

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

MYCIO Wealth Partners's KZIA Position: Q4 2015 in Review

MYCIO Wealth Partners sold out of Kazia Therapeutics (KZIA) in Q4 2015, closing a stake of 10 shares — an estimated $5K sold.

MYCIO Wealth Partners first reported a position in KZIA in Q2 2015 and held it in 2 quarters. The position peaked at $8K in Q2 2015. 6 funds tracked by Wall St. Rank hold KZIA as of Q4 2015.

  • MYCIO Wealth Partners reported no remaining Kazia Therapeutics position as of Q4 2015 after selling out during the quarter.
  • MYCIO Wealth Partners sold 10 Kazia Therapeutics shares in Q4 2015, an estimated $5K.
  • MYCIO Wealth Partners first reported a position in Kazia Therapeutics in Q2 2015 and held it in 2 quarters.
  • MYCIO Wealth Partners's Kazia Therapeutics position peaked at $8K in Q2 2015.
  • 6 funds tracked by Wall St. Rank held Kazia Therapeutics as of Q4 2015.

Based on MYCIO Wealth Partners's 13F filing for Q4 2015, filed 5 Feb 2016.